GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneThera Inc (OTCPK:GTHR) » Definitions » E10

GeneThera (GeneThera) E10 : $-0.05 (As of Sep. 2022)


View and export this data going back to 2000. Start your Free Trial

What is GeneThera E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

GeneThera's adjusted earnings per share data for the three months ended in Sep. 2022 was $-0.004. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.05 for the trailing ten years ended in Sep. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-23), GeneThera's current stock price is $0.006. GeneThera's E10 for the quarter that ended in Sep. 2022 was $-0.05. GeneThera's Shiller PE Ratio of today is .


GeneThera E10 Historical Data

The historical data trend for GeneThera's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneThera E10 Chart

GeneThera Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.07 - -0.05 -0.05

GeneThera Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.05 -0.05 -0.05 -0.05

Competitive Comparison of GeneThera's E10

For the Biotechnology subindustry, GeneThera's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GeneThera's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeneThera's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where GeneThera's Shiller PE Ratio falls into.



GeneThera E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GeneThera's adjusted earnings per share data for the three months ended in Sep. 2022 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=-0.004/125.2265*125.2265
=-0.004

Current CPI (Sep. 2022) = 125.2265.

GeneThera Quarterly Data

per share eps CPI Adj_EPS
201212 -0.030 96.871 -0.039
201303 -0.010 98.209 -0.013
201306 -0.010 98.518 -0.013
201309 -0.010 98.790 -0.013
201312 -0.010 98.326 -0.013
201403 -0.010 99.695 -0.013
201406 -0.010 100.560 -0.012
201409 -0.004 100.428 -0.005
201412 0.000 99.070 0.000
201503 -0.010 99.621 -0.013
201506 -0.004 100.684 -0.005
201509 -0.010 100.392 -0.012
201512 -0.010 99.792 -0.013
201603 -0.010 100.470 -0.012
201606 -0.010 101.688 -0.012
201609 -0.010 101.861 -0.012
201612 0.000 101.863 0.000
201703 -0.010 102.862 -0.012
201706 -0.004 103.349 -0.005
201709 -0.004 104.136 -0.005
201712 0.000 104.011 0.000
201803 -0.010 105.290 -0.012
201806 -0.010 106.317 -0.012
201809 -0.010 106.507 -0.012
201812 -0.070 105.998 -0.083
201903 -0.004 107.251 -0.005
201906 -0.004 108.070 -0.005
201909 0.001 108.329 0.001
201912 0.000 108.420 0.000
202003 -0.004 108.902 -0.005
202006 -0.010 108.767 -0.012
202009 -0.010 109.815 -0.011
202012 -0.007 109.897 -0.008
202103 -0.010 111.754 -0.011
202106 -0.010 114.631 -0.011
202109 -0.010 115.734 -0.011
202112 -0.010 117.630 -0.011
202203 -0.004 121.301 -0.004
202206 -0.004 125.017 -0.004
202209 -0.004 125.227 -0.004

Add all the adjusted EPS together and divide 10 will get our e10.


GeneThera  (OTCPK:GTHR) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


GeneThera E10 Related Terms

Thank you for viewing the detailed overview of GeneThera's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


GeneThera (GeneThera) Business Description

Traded in Other Exchanges
N/A
Address
3051 W 105th Avenue, Suite 350251, Westminster, CO, USA, 80035
GeneThera Inc is a biotechnology company using its proprietary molecular sciences and technologies dedicated to eradicating diseases such as COVID-19, Paratuberculosis, Mad Cow Disease, Chronic Wasting Disease, and E.coli and Salmonella infections. It focuses on developing novel molecular diagnostic tests, therapeutics, and vaccines through its proprietary robotic technologies. Its Molecular Robotic/AI Platform and Therapeutic strategy (MORAPAT) is designed to prevent the spread of disease from animals and at the same time, allow better control of zoonotic infectious agents. The company has also developed a molecular system for the detection of Mycobacterium Avian Paratuberculosis in the milk of infected dairy cows.
Executives
Avel Kolesnikov director 11353 COLONY CIRCLE, BROOMFIELD CO 80020
Mcnece Elmer Roy Jr 10 percent owner 632 CANTRILL DRIVE, DAVIS CA 95616
Fidra Holdings Ltd 10 percent owner CABLE BEACH COURT, ONE WEST BAY STREET, NASSAU BAHAMAS C5 00000
Steven Michael Grubner director, officer: Chief Financial Officer 728 S. PRAIRIE AVENUE, BARRINGTON IL 60010
Antonio Milici director, 10 percent owner, officer: Chief Executive Officer 3930 YOUNGFIELD, WHEAT RIDGE CO 80033
Tannya L Irizarry director, 10 percent owner, officer: Chief Administative Officer 11880 ANTLER TR, LITTLETON CO 80127

GeneThera (GeneThera) Headlines

No Headlines